Clinical efficacy of the co-administration of Turmeric and Black seeds (Kalongi) in metabolic syndrome - A double blind randomized controlled trial - TAK-MetS trial

Complementary Therapies in Medicine

Volumn 23, Issue 2, 2015, Pages 165-174

  Amin, F ^a   Islam, N ^b   Anila, Nfn ^c   Gilani, A H ^a,d  

^a AGA KHAN UNIVERSITY MEDICAL COLLEGE   (Pakistan)

^b AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^c QUEENS HOSPITAL CENTER   (United States)

^d MEKELLE UNIVERSITY   (Ethiopia)

Author keywords

Black seeds; Clinical efficacy; Co administration; Metabolic syndrome; Synergism; Turmeric

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HERBACEOUS AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL; TURMERIC; PLANT MEDICINAL PRODUCT;

ADULT; ARTICLE; BLACK CUMIN; BODY FAT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; GLUCOSE BLOOD LEVEL; HIP CIRCUMFERENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NAUSEA; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SKIN PRURITUS; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WEAKNESS; CHEMISTRY; CURCUMA; MIDDLE AGED; PAKISTAN; PHYTOTHERAPY;

ADULT; CURCUMA; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NIGELLA SATIVA; PAKISTAN; PHYTOTHERAPY; PLANT PREPARATIONS;

EID: 84926410186     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2015.01.008     Document Type: Article

References (42)

1. Mottillo S., Filion K.B., Genest J., Joseph L., Pilote L., Poirier P., et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010, 56(14):1113-1132.
2. Ilanne-Parikka P., Eriksson J.G., Lindstrom J., Peltonen M., Aunola S., Hamalainen H., et al. Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish Diabetes Prevention Study. Diabetes Care 2008, 31(4):805-807.
3. Abete I., Astrup A., Martinez J.A., Thorsdottir I., Zulet M.A. Obesity and the metabolic syndrome: role of different dietary macronutrient distribution patterns and specific nutritional components on weight loss and maintenance. Nutr Rev 2010, 68(4):214-231.
4. de Lorgeril M., Salen P., Abramson J., Dodin S., Hamazaki T., Kostucki W., et al. Cholesterol lowering, cardiovascular diseases, and the rosuvastatin-JUPITER controversy: a critical reappraisal. Arch Intern Med 2010, 170(12):1032-1036.
5. Ray K.K., Seshasai S.R., Erqou S., Sever P., Jukema J.W., Ford I., et al. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. Arch Intern Med 2010, 170(12):1024-1031.
6. Hu F.B. Prevention of diabetes and cardiovascular disease among prediabetic individuals: lifestyle versus drug interventions. Eur J Prev Cardiol 2011, 18(6):810-812.
7. Reilly M.P., Rader D.J. The metabolic syndrome: more than the sum of its parts?. Circulation 2003, 108(13):1546-1551.
8. Power M., Pratley R. Alternative and complementary treatments for metabolic syndrome. Curr Diabetes Rep 2011, 11(3):173-178.
9. Graf B.L., Raskin I., Cefalu W.T., Ribnicky D.M. Plant-derived therapeutics for the treatment of metabolic syndrome. Curr Opin Investig Drugs 2010, 11(10):1107-1115.
10. Anderson J.G., Taylor A.G. Use of complementary therapies by individuals with or at risk for cardiovascular disease: results of the 2007 National Health Interview Survey. J Cardiovasc Nurs 2012, 27(2):96.
11. Gilani A.H. Novel developments from natural products in cardiovascular research. Phytother Res 1998, 12:66-69.
12. Amin F., Mehmood M.H., Siddiqui B.S., Khatoon N., Gilani A.H. Co-administration of Black seeds and Turmeric shows enhanced efficacy in preventing metabolic syndrome in fructose-fed rats. J Cardiovasc Pharmacol 2014, published online. 10.1097/FJC.0000000000000179.
13. Sharma N., Sharma P., Jasuja N.D., Joshi C. Hypocholesterolemic and antioxidant potentials of some plants and herbs: a review. J Zool Sci 2013, 1(2):26-42.
14. Sabzghabaee A.M., Dianatkhah M., Sarrafzadegan N., Asgary S., Ghannadi A. Clinical evaluation of Nigella sativa seeds for the treatment of hyperlipidemia: a randomized, placebo controlled clinical trial. Med Arhiv 2012, 66(3):198-200.
15. Tasawar Z., Siraj Z., Ahmad N., Lashari M.H. The effects of Nigella sativa (Kalonji) on lipid profile in patients with stable coronary artery disease in Multan, Pakistan. Pak J Nutr 2011, 10(2):162-167.
16. Mathur M.L., Gaur J., Sharma R., Haldiya K.R. Antidiabetic properties of a spice plant Nigella sativa. J Endocrinol Metab 2011, 1(1):1-8.
17. Na L.X., Li Y., Pan H.Z., Zhou X.L., Sun D.J., Meng M., et al. Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial. Mol Nutr Food Res 2013, 57(9):1569-1577.
18. Mohammadi A., Sahebkar A., Iranshahi M., Amini M., Khojasteh R., Ghayour-Mobarhan M., et al. Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial. Phytother Res 2013, 27(3):374-379.
19. Pashine L., Singh J., Vaish A., Ojha S., Mahdi A. Effect of turmeric (Curcuma longa) on overweight hyperlipidemic subjects: double blind study. Indian J Commun Health 2012, 24(2):113-117.
20. Khajehdehi P., Zanjaninejad B., Aflaki E., Nazarinia M., Azad F., Malekmakan L., et al. Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: a randomized and placebo-controlled study. J Ren Nutr 2012, 22(1):50-57.
21. Wickenberg J., Ingemansson S.L., Hlebowicz J. Effects of Curcuma longa (turmeric) on postprandial plasma glucose and insulin in healthy subjects. Nutr J 2010, 9(1):43.
22. Gilani A.H., Rahman A.U. Trends in ethnopharmacology. J Ethnopharmacol 2005, 100(1-2):43-49.
23. van der Worp H.B., Howells D.W., Sena E.S., Porritt M.J., Rewell S., O'Collins V., et al. Can animal models of disease reliably inform human studies?. PLoS Med 2010, 7(3):e1000245. 10.1371/journal.pmed.1000245.
24. Antonopoulos S. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002, 106(3143):3421.
25. Lenfant C., Chobanian A.V., Jones D.W., Roccella E.J. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003, 42(6):1206.
26. Datau E.A., Wardhana, Surachmanto E.E., Pandelaki K., Langi J.A., Fias Efficacy of Nigella sativa on serum free testosterone and metabolic disturbances in central obese male. Acta Med Indones 2010, 42(3):130-134.
27. Qidwai W., Hamza H.B., Qureshi R., Gilani A.H. Effectiveness, safety, and tolerability of powdered Nigella sativa (kalonji) seed in capsules on serum lipid levels, blood sugar, blood pressure, and body weight in adults: results of a randomized, double-blind controlled trial. J Altern Complement Med 2009, 15(6):639-644.
28. Bamosa A.O., Kaatabi H., Lebdaa F.M., Elq A.M., Al-Sultanb A. Effect of Nigella sativa seeds on the glycemic control of patients with type 2 diabetes mellitus. Indian J Physiol Pharmacol 2010, 54(4):344-354.
29. Bhatti A., Rehman F.U., Khan M., Marwa S. Effect of prophetic medicine Kalonji (Nigella sativa L.) on lipid profile of human beings, an in vivo approach. World Appl Sci J 2009, 6(8):1053-1057.
30. Pungcharoenkul K., Thongnopnua P. Effect of different curcuminoid supplement dosages on total in vivo antioxidant capacity and cholesterol levels of healthy human subjects. Phytother Res 2011, 25(11):1721-1726.
31. Ramirez-Bosca A., Soler A., Carrion M.A., Diaz-Alperi J., Bernd A., Quintanilla C., et al. An hydroalcoholic extract of Curcuma longa lowers the apo B/apo A ratio. Implications for atherogenesis prevention. Mech Ageing Dev 2000, 119(1-2):41-47.
32. Usharani P., Mateen A.A., Naidu M.U., Raju Y.S., Chandra N. Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study. Drugs R&D 2008, 9(4):243-250.
33. Alwi I., Santoso T., Suyono S., Sutrisna B., Suyatna F.D., Kresno S.B., et al. The effect of curcumin on lipid level in patients with acute coronary syndrome. Acta Med Indones 2008, 40(4):201-210.
34. Goel A., Kunnumakkara A.B., Aggarwal B.B. Curcumin: from kitchen to clinic. Biochem Pharmacol 2008, 75(4):787-809.
35. Taylor A.J., Wong H., Wish K., Carrow J., Bell D., Bindeman J., et al. Validation of the MEDFICTS dietary questionnaire: a clinical tool to assess adherence to American Heart Association dietary fat intake guidelines. Nutr J 2003, 2:4.
36. Bassett D.R. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003, 35(8):1396.
37. Bowling J.L., Katayev A. An evaluation of the Roche Cobas c 111. Lab Med 2010, 41(7):398.
38. Perez-Torres I., Ruiz-Ramirez A., Banos G., El-Hafidi M. Hibiscus sabdariffa Linnaeus (Malvaceae), curcumin and resveratrol as alternative medicinal agents against metabolic syndrome. Cardiovasc Hematol Agents Med Chem 2013, 11(1):25-37.
39. Dehkordi F.R., Kamkhah A.F. Antihypertensive effect of Nigella sativa seed extract in patients with mild hypertension. Fundam Clin Pharmacol 2008, 22(4):447-452.
40. Wing R.R., Lang W., Wadden T.A., Safford M., Knowler W.C., Bertoni A.G., et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care 2011, 34(7):1481-1486.
41. Nakmareong S., Kukongviriyapan U., Pakdeechote P., Donpunha W., Kukongviriyapan V., Kongyingyoes B., et al. Antioxidant and vascular protective effects of curcumin and tetrahydrocurcumin in rats with L-NAME-induced hypertension. Naunyn Schmied Arch Pharmacol 2011, 383(5):519-529.
42. Babio N., Balanza R., Basulto J., Bullo M., Salas-Salvado J. Dietary fibre: influence on body weight, glycemic control and plasma cholesterol profile. Nutr Hosp 2010, 25(3):327-340.